Stockreport

Altamira Therapeutics to Host First Half 2024 Financial Results and Business Update Call on September 24, 2024

Altamira Therapeutics Ltd. - Common Shares  (CYTO) 
PDF Hamilton, Bermuda, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Altamira Therapeutics Ltd. ("Altamira" or the "Company") (Nasdaq: CYTO), a company providing nanoparticle-based t [Read more]